Novo Nordisk: Can CagriSema Show 25% Weight Loss In REDEFINE-1 Trial? US$ 25.41 Min. order: 1 piece ★★★★★ 4.1 (32 reviews) Sold : Login>>
Novo Nordisk's Cagrilintide shows promising weight loss in REDEFINE-1 sub-analysis, unveiled at EASD 2025 US$ 21.85 Min. order: 1 piece ★★★★★ 4.0 (127 reviews) Sold : Login>>
Cagrilintide is an amylin analogue that helps regulate appetite. In a randomized trial of over 3400 patients who were overweight or obese and had ≥1 weight-related complication, individuals assigned to a combination US$ 22.90 Min. order: 1 piece ★★★★★ 4.7 (228 reviews) Sold : Login>>
Once-weekly cagrilintide for weight management in people with overweight and obesity: a multicentre, randomised, double-blind, placebo-controlled and active-controlled, dose-finding phase 2 trial US$ 22.52 Min. order: 1 piece ★★★★★ 4.6 (162 reviews) Sold : Login>>
Subcutaneous Cagrilintide, Semaglutide Shows Significant Weight Loss in Type 2 Diabetes Trial US$ 22.58 Min. order: 1 piece ★★★★★ 4.3 (300 reviews) Sold : Login>>